GlobeNewsWire
27 Oct 2025, 12:43 UTC · 51w ago
Verdict
Headline takes no side. We score AVR +0.80 — strongly bullish.
+0.80strongly bullish
More positive than 91% of ticker scores this week
Which stocks this story touches
More positive than 91% of ticker scores this week
The company is presenting encouraging one-year clinical outcomes for its DurAVR valve and advancing its global pivotal trial.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
5h ago
+23.6%
Price agrees with the score
$6.18 vs $5.00 close before publication (Oct 24) · not market-adjusted
AVR chart →
